The cytotoxicity-guided study of the dichloromethane and ethanol extracts of Thymus mastichina L. using the HCT colon cancer cell line allowed the identification of nine compounds, sakuranetin (1), sterubin (2), oleanolic acid (3), ursolic acid (4), lutein (5), β-sitosterol (6), rosmarinic acid (7), 6hydroxyluteolin-7-O-β-glucopyranoside (8), and 6-hydroxyapigenin-7-O-β-glucopyranoside (9). All compounds were tested for their cytotoxicity against the HCT colon cancer cell line. Compound 4 showed cytotoxicity with GI 50 value of 6.8 µg/mL. A fraction composed of a mixture (1:1) of triterpenoid acids 3 and 4 displayed improved cytotoxicity with a GI 50 of 2.8 g/mL suggesting a synergistic behavior. This is the first report on the chemical constituents of Thymus mastichina L. based on structural assignments by spectroscopic analysis. The presence of these constituents identified by colon cancer cytotoxicity-guided activity indicates that extracts of T. mastichina L. may have a protective effect against colon cancers.
Thymus mastichina L. (Lamiaceae) is a small sub-woody shrub that grows in land clearings, rocky and dry, especially in thickets zones, and is strongly resistant to frost, diseases and pests. It is an indigenous species in Portuguese territory and is unique in the Iberian Peninsula (Iberian endemism) [1] . This plant of strong scent of eucalyptus has medicinal properties such as analgesic, antiseptic and antispasmodic, and can be used fresh or dried, infused in cases of flu, colds, indigestion, sore throat and hoarseness. The leaves are traditionally used as spice, as salt substitute, and as enhancer of the flavor of different foods. According to pharmacopoeias and local cuisine the medicinal and aromatic plants are important as dietary supplements, providing bioactive compounds [2] . The essential oil composition of the aerial parts of T. mastichina comprises oxygencontaining monoterpenes and sesquiterpenes among which 1,8-cineole and linalool are the main constituents [3] [4] [5] [6] [7] . The terpenoids, total fat content, crude protein, ash, and carbohydrates, vitamins (ascorbic acid and tocopherols) and total phenolics of T. mastichina were described [8, 9] . The total phenolic content of T. mastichina extracts was described as antioxidant and as antiinflammatory [10] .
Despite the references to this species the knowledge of its chemical composition is incomplete. As part of our search for cytotoxic compounds and following a previous screen of the ethanol extract using HCT colon cancer cell line T. mastichina was studied according to a cytotoxicity-guided procedure. The main constituents were identified as flavanones, triterpenoids, a xanthophyll, a steroid, a phenolic acid and flavone glycosides.
Dichloromethane and ethanol extracts of the aerial parts of T. mastichina were assayed against the HCT colon cancer cell line (GI 50 value of 2.8 µg/ml and 12.0 µg/mL, respectively). The ethanol extract was split into insoluble and soluble portions in methanol:water (3:1) and both extracts were tested by the same model assay (GI 50 value of 2.6 µg/mL and GI 50 > 20 µg/mL, respectively). This study showed that the cytotoxicity is retained in the dichloromethane and in the insoluble portion of the ethanol extracts. The chemical composition analysis of the extracts was followed by cytotoxicity-guided procedure. The dichloromethane extract was chromatographed over silica gel columns and purifications were performed over preparative TLC plates to afford the flavanones sakuranetin (1) and sterubin (2), the triterpenoids oleanolic acid (3) and ursolic acid (4), and the xanthophyll lutein (5). By identical chromatographic method as described above the insoluble portion of the ethanol extract afforded oleanolic acid (3), ursolic acid (4), and the steroid β-sitosterol (6) . The soluble portion of the ethanol extract was chromatographed over RP-18 silica gel columns to afford rosmarinic acid (7) , and the flavone glycosides 6hydroxyluteolin-7-O-glucopyranoside (8) and 6-hydroxyapigenin-7-O-glucopyranoside (9) . Structures are represented in Fig 1. The structures were assigned by [α] D t values, IR, 1D and 2D NMR experiments, mass spectrometry and comparison with literature data. Although compounds 1-9 are well-known, they are reported here for the first time in T. mastichina.
All the compounds were assayed individually against the HCT colon cancer cell line. In these conditions ursolic acid (4) displayed a value of GI 50 of 6.8 µg/ml ( Figure 2 ) and the other compounds were inactive, i.e. showing GI 50 > 20 µg/mL (data not shown). The GI 50 value found for ursolic acid (6.8 ug/ml or 14.9 uM) is in line with values found in the literature for other anti-cancer compounds tested in the same HCT colon cancer cell line [11] . A fraction containing a mixture (1:1) of oleanolic acid (3) and ursolic acid (4) isolated in one of the chromatographic procedures exhibited better cytotoxicity than the pure ursolic acid (4) (GI 50 = 2.8 µg/mL). These results were confirmed by performing identical assays with commercial compounds (for compound 4 GI 50 = 7.1 µg/mL and for the mixture (1:1) of compounds 3 and 4 GI 50 = 3.4 µg/mL). In . Optical rotations were measured on a Perkin Elmer 241MC polarimeter (c in g/100 mL) and the solvent is indicated in each case. FT-IR spectra were recorded on a Perkin Elmer Spectrum 1000 spectrometer in KBr disks. One and two dimensional NMR spectra were run on a Bruker ARX 400 or Avance III 600 apparatus, using CDCl 3 , CD 3 OD, pyridine-d 5 or D 2 O as solvents, and a standard pulse sequence. The spectra were calibrated using the residual solvent signals. MS spectra were run on a Micromass GCT mass spectrometer at the analytical services laboratory of REQUIMTE (Portugal) and on a Brucker Microtof mass spectrometer at USC (Spain).
Plant material:
In this study specimens of T. mastichina that are commercialised in Portugal and in Spain were used. The vegetal material were originally collected in the region of Porto (Portugal) and Murcia (Spain) and vegetatively propagated. A voucher specimen was prepared for the plant material (AbelOliva Acc. No 03-III-11) and was deposited at LISE (Herbarium of the Estação Agronomica Nacional, INIAV, I.P., Oeiras, Portugal). The comparison of the TLC plates and the 1 H NMR profiles of the dichloromethane and ethanol extracts of the two specimens showed that both plants have superimposable compositions. This conclusion allowed us to study both plants indifferently.
Extraction: Plant extractions were performed at room temperature for 12 hours for each batch (three batches for each solvent). Dried and powdered aerial parts of T. mastichina (270 g), originally collected in the Porto region (Portugal) and vegetatively propagated, were extracted with n-hexane (inactive extract against the model assay used). One half of the fat-washed plant material was then extracted with dichloromethane and the other half was extracted with ethanol, affording 4.5 g (GI 50 = 2.8 µg/mL) and 14.0 g (GI 50 = 12.0 µg/mL), respectively. The ethanol extract was dissolved in Chemical constituents of Thymus mastichina Natural Product Communications Vol. 7 (11) 2012 1493 methanol:water (3:1) and cooled in an ice/sodium chloride bath overnight [12] . The precipitate was recovered by filtration and consists on the insoluble portion of the ethanol extract (2.2 g; GI 50 = 2.6 µg/mL). The remaining solution was evaporated to dryness under vacuum to afford the soluble portion of the ethanol extract (9.9 g; GI 50 > 20 µg/mL). From this fraction 1.7 g were further chromatographed as described below. Dried and powdered aerial parts of T. mastichina (1 Kg), originally collected in the Murcia region (Spain) and vegetatively propagated, were defatted with nhexane and then extracted with dichloromethane and with ethanol, affording 28.5 g, and 104.7 g, respectively. From the ethanol extract 60 g were partitioned as previously described, affording 4.2 g of the insoluble portion. The dichloromethane and insoluble portion of the ethanol extract were further chromatographed as described.
Isolation:
The dichloromethane extract was chromatographed on Si gel 60 using a gradient of n-hexane/EtOAc to yield fractions a -j. Fractions g, h and i were further purified on Si gel columns and/or preparative plates using mixtures of n-hexane/EtOAc of different polarities. From fraction g oleanolic acid (3) The methanol:water (3:1) insoluble portion of the ethanol extract was chromatographed on a Si gel column using a gradient of nhexane/EtOAc to yield twelve fractions (1 -12) . Fractions 6 and 10 were further chromatographed on Si gel columns and/or preparative plates using mixtures of n-hexane/Et 2 O or CH 2 Cl 2 /MeOH of different polarities. From fraction 6 β-sitosterol (6) (6.2 mg) was obtained. The chlorophylls present in fraction 9 were removed under reflux of 20 mL of CH 2 Cl 2 /MeOH (1:1) mixture with activated charcoal. Fraction 9a thus obtained (96.6 mg) was chromatographed as previously described. From fraction 9a a mixture of oleanolic (3) and ursolic acid (4) (1:1) was separated (77.1 mg). From fraction 10 a mixture (1:1) of oleanolic acid (3) and ursolic acid (4) (11.4 mg), and pure ursolic acid (4) (15.0 mg) were obtained. 
Sakuranetin

Evaluation of cytotoxic activity:
The cytotoxic activity of the extracts, chromatographic fractions and pure compounds was evaluated against the HCT (P132) colon cancer cell line according to established protocols, described below.
Cell line culture:
Human colorectal carcinoma HCT 116 cells were cultured in DMEM-HG supplemented with 5% fetal bovine serum, 6 mM L-glutamine, 4.5 g/L glucose, 100 mU/mL Penicillin and 100 µg/mL Streptomycin. Cells were cultured in a humidified atmosphere with 7% CO 2 at 37°C.
Sulforhodamine B assay:
The cytotoxic effect of the test compounds on cell growth was determined by the sulforhodamine B (SRB) colorimetric assay [26] . Briefly, cells were seeded into 96well microtiter plates, at a plating density of 8000 cells per well. After cell inoculation, the plates were incubated at 37°C, 7% CO 2 , humidified atmosphere for 24 h prior to addition of the test compounds.
After 24 h, one plate was fixed with trichloroacetic acid, to represent a measurement of the cell population at the time of drug addition (Tz). Test compounds were solubilized in dimethyl sulfoxide to a stock-concentration of 20 mg/mL and diluted to twice the desired final maximum test concentration, with complete culture medium. Six additional 10-fold serial dilutions were made to provide a total of seven drug concentrations, plus control. 100 µL of the different drug dilutions were added to the appropriate wells already containing 100 µL of medium.
Following drug addition, the plates were incubated for an additional 48 h, at 37°C, 7% CO 2 humidified atmosphere. The assay ended by the fixation of the cells by addition of 50 µL of cold 50% (w/v) TCA (final concentration, 10% TCA) and incubated for 1 h, at 4°C. The supernatant was discarded and the plates were washed four times with distilled water and air dried. SRB solution (100 µL) at 0.4% (w/v) in 1% acetic acid was added to each well and plates were incubated for 30 minutes at room temperature (RT), protected
